First Time Loading...

Medibio Ltd
ASX:MEB

Watchlist Manager
Medibio Ltd Logo
Medibio Ltd
ASX:MEB
Watchlist
Price: 0.02 AUD Market Closed
Updated: May 16, 2024
Section:
 

Wall Street
Price Targets

MEB Price Targets Summary
Medibio Ltd

There are no price targets for MEB.
MEB Lowest Forecast
Wall Street Target
Not Available
MEB Average Forecast
Wall Street Target
Not Available
MEB Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Medibio Ltd Competitors:
Price Targets
SDGR
Schrodinger Inc
59% Upside
GPI
GPI SpA
25% Upside
B
2251
Beijing Airdoc Technology Co Ltd
30% Upside
2413
M3 Inc
50% Upside
SDGR
Schrodinger Inc
59% Upside
GPI
GPI SpA
25% Upside
B
2251
Beijing Airdoc Technology Co Ltd
30% Upside
2413
M3 Inc
50% Upside
EMIS
EMIS Group PLC
15% Downside
4DX
4DMedical Ltd
88% Upside
NXU
Nexus AG
19% Upside
M7T
Mach7 Technologies Ltd
89% Upside

Revenue
Forecast

Revenue Estimate
Medibio Ltd

For the last 8 years the compound annual growth rate for Medibio Ltd's revenue is 18%. The projected CAGR for the next 5 years is 33%.

18%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medibio Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medibio Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
MEB intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEB stock valuation using valuation multiples.
Wall Street Estimates
MEB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEB's stock price target?
Not Available

MEB doesn't have any price targets made by Wall Street professionals.

What is Medibio Ltd's Revenue forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Medibio Ltd's revenue is 18%. The projected CAGR for the next 5 years is 33%.

ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.